HOME >> MEDICINE >> NEWS
Study examined switching rates between Allegra® (fexofenadine HCl) and Claritin®

CHICAGO, Il., November 13, 1999 - A higher percentage of seasonal allergic rhinitis (SAR) patients switched to Allegra® (fexofenadine HCl) from Claritin® (loratadine) than vice versa in the spring and fall of 1997 and 1998, according to the results of a study of more than 33,000 patients presented at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI).

The findings are based on "Prescribing Patterns of Non-sedating Antihistamines and Daily Dose Differences in a Managed Care Population," a study that evaluated the continuity of allergy treatment by drug and by allergy season (spring, fall 1997- 1998). The retrospective study analyzed data from physicians' claims from 12 United Healthcare health plans.

During the study period, an average of 12.6 percent of patients taking Claritin switched to Allegra versus 10.0 percent of patients who switched from Allegra to Claritin. "Usage data about newer therapies is important for managed care organizations to analyze so they can understand physician and patient preferences," said Lewis Roht, M.D., Director of Drug Surveillance and Epidemiology at Hoechst Marion Roussel.

Other Studies
Other data presented at the ACAAI meeting by Hoechst Marion Roussel included:

  • A four-week, multicenter, double-blind, randomized, placebo-controlled study which showed that Allegra at doses of 20, 60, 120, and 240 mg reduced pruritus and number of wheals scores over a four-week period for the treatment of chronic idiopathic urticaria (CIU), also known as hives. The study demonstrated that all doses of Allegra greatly reduced the symptoms compared to placebo (P0.0115). Additionally, patients who received Allegra experienced significantly less interference with sleep and daily activities than patients who received placebo (P0.0014). Twice-daily doses of 60 mg or greater were most effective. Adverse events occurred with similar incidence in all treatment groups, with
    '"/>


Contact: Suzanne Wiele
816-966-3475
Porter Novelli
12-Nov-1999


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
Breaking Medicine Technology:
Cached News: